STE STERIS Plc

STERIS Expands Healthcare Consumables Offering with Acquisition of Key Surgical for approximately $850 million

STERIS Expands Healthcare Consumables Offering with Acquisition of Key Surgical for approximately $850 million
EN
06/10/2020

Underlying

STESTERIS Plc

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on STERIS Plc

 PRESS RELEASE
Free
STE STERIS PLC

STERIS Announces Financial Results for Fiscal 2025 Fourth Quarter and ...

STERIS Announces Financial Results for Fiscal 2025 Fourth Quarter and Full Year Full year fiscal 2025 revenue from continuing operations increased 6%; constant currency organic revenue growth was 6% Full year fiscal 2025 as reported diluted EPS from continuing operations increased to $6.16; adjusted EPS per diluted share increased to $9.22Fiscal 2026 outlook provided DUBLIN, IRELAND, May 14, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2025 fourth quarter and full year ended March 31, 2025. Total revenue fro...

May 14, 2025 1 EN
 PRESS RELEASE
Free
STE STERIS PLC

STERIS Declares Dividend of $0.57 per share

STERIS Declares Dividend of $0.57 per share DUBLIN, IRELAND, May 07, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.57 per share. The dividend is payable on June 26, 2025, to shareholders of record at the close of business on June 10, 2025.   Additional information about the U.S. tax treatment of dividends, including required Forms 8937, is available at -ir.com. STERIS is a leading global provider of products and services that support patient care with an emphasis on infectio...

May 7, 2025 1 EN
 PRESS RELEASE
Free
STE STERIS PLC

STERIS to Host a Conference Call for Fiscal 2025 Fourth Quarter and Fu...

STERIS to Host a Conference Call for Fiscal 2025 Fourth Quarter and Full Year Financial Results on May 15, 2025 DUBLIN, IRELAND, April 22, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2025 fourth quarter and full year financial results at 9:00 a.m. ET on May 15, 2025. The conference call can be heard live at or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. A press release detailing f...

April 22, 2025 1 EN
 PRESS RELEASE
Free
STE STERIS PLC

STERIS Announces Financial Results for Fiscal 2025 Third Quarter

STERIS Announces Financial Results for Fiscal 2025 Third Quarter Total revenue from continuing operations increased 6%; constant currency organic revenue grew 6% As reported diluted EPS from continuing operations increased to $1.75; adjusted EPS increased to $2.32Fiscal 2025 outlook updated DUBLIN, IRELAND, Feb. 05, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2025 third quarter ended December 31, 2024. Total revenue from continuing operations for the third quarter of fiscal 2025 increased 6% to $1.4 billion...

February 5, 2025 1 EN
 PRESS RELEASE
Free
STE STERIS PLC

STERIS Declares Dividend of $0.57 per share

STERIS Declares Dividend of $0.57 per share DUBLIN, IRELAND, Jan. 28, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.57 per share. The dividend is payable on March 21, 2025, to shareholders of record at the close of business on February 20, 2025.   Additional information about the U.S. tax treatment of dividends, including required Forms 8937, is available at -ir.com. STERIS is a leading global provider of products and services that support patient care with an emphasis on i...

January 28, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch